Latest Liquidity News

Beetaloo Energy Australia Limited has completed a $35 million capital raise and successfully finished hydraulic stimulation of its Carpentaria-5H well, setting the stage for production expected in 2026. Traditional Owner consent and strong liquidity underpin the company’s next development phase.

Cobre Limited’s CBEO securities have been suspended from trading pending regulatory compliance, raising questions about the company’s next steps and investor impact.

Cullen Resources Limited reported significant progress across its gold exploration portfolio in Western Australia and Finland, including new project acquisitions and active joint venture drilling campaigns.

MedAdvisor Solutions reported a 16.6% revenue decline in 4Q FY25, driven by US market challenges, while completing the sale of its ANZ business and initiating a strategic review of its US operations.

Alma Metals has bolstered its Briggs Copper JV Project with a $1.06 million capital raise and an updated resource estimate that now includes silver. The company is progressing a scoping study and preparing for significant drilling to unlock further value.

Omega Oil and Gas reports strong appraisal progress at its Canyon Project, highlighting premium light crude oil and multiple stacked pay zones, supported by a robust $15.1 million pro forma cash position.

Micro-X has landed a significant supply agreement with a top US healthcare provider for its Rover Plus mobile X-ray units, while progressing clinical trials and development milestones for its innovative CT imaging products.

Sunshine Metals Limited reported a cautious quarterly cash flow with A$1.9 million in cash and 1.4 quarters of funding runway, highlighting the discretionary nature of its exploration activities and plans to secure further financing.

Brightstar Resources has delivered a strong Definitive Feasibility Study for its Laverton and Menzies Gold Projects, targeting over 338,000 ounces of gold with promising financial returns, while ramping up underground mining operations and securing $50 million in capital.

AMCIL Limited reported a net profit of $6.7 million for FY2025, down from $7.5 million the previous year, and announced a fully franked total dividend of 6.5 cents per share, boosted by a special capital gains payout.

Neurotech International reports encouraging Phase I human pharmacokinetic results for its pediatric cannabinoid drug NTI164, alongside published clinical trial data in Rett Syndrome and key regulatory progress in the US and Australia.

Energy Resources of Australia Ltd narrowed its half-year loss to $35 million as it pressed ahead with the complex rehabilitation of the Ranger Project Area, backed by $1.24 billion in cash and investments. Meanwhile, Rio Tinto moves to compulsorily acquire remaining shares, signaling a new chapter for ERA’s future.